Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Antineoplastic agents associated with cardiotoxicity.
| Antineoplastic agent | Estimated prevalence of cardiotoxicity (%) | Ref. |
|---|---|---|
| Adriamycin | 5–15 (heart failure); ≤50 (subclinical cardiotoxicity) | [10,11,13] |
| Trastuzumab | 20–33 | [43–45] |
| Sunitinib | 8–15 (heart failure or cardiomyopathy) | [52] |
| Dasatinib | 4 (heart failure or cardiomyopathy) | [52] |
| Sorafenib | 3–17 | [52] |
| Imatinib | 0.5–1.7 | [52] |
| Bevacizumab | 1.6 | [78] |
